Narrow search
Showing 1 - 10 of 94
Cover Image
Was part D a giveaway to the pharmaceutical industry?
Newhouse, Joseph P.; Seiguer, Erica; Frank, Richard G. - In: Inquiry : a journal of health care organization, … 44 (2007) 1, pp. 15-25
Persistent link: https://www.econbiz.de/10003570316
Cover Image
Are drugs substitutes or complements for intensive (and expensive) medical treatment
Zhang, Yuting; Newhouse, Joseph P.; Baicker, Katherine - In: The American economic review 101 (2011) 3, pp. 393-397
Persistent link: https://www.econbiz.de/10009266605
Cover Image
A primer on the economics of prescription pharmaceutical pricing in health insurance markets
Berndt, Ernst R.; McGuire, Thomas G.; Newhouse, Joseph P. - In: Forum for health economics & policy : an evolving … 14 (2011) 2, pp. 1-28
Persistent link: https://www.econbiz.de/10009620010
Cover Image
A primer on the economics of prescription pharmaceutical pricing in health insurance markets
Berndt, Ernst R.; McGuire, Thomas G.; Newhouse, Joseph P. - 2011
Persistent link: https://www.econbiz.de/10008936343
Cover Image
Should drug prices be negotiated under Part D of Medicare? : and if so, how?
Frank, Richard G.; Newhouse, Joseph P. - In: Health affairs : at the intersection of health, health … 27 (2008) 1, pp. 33-43
Persistent link: https://www.econbiz.de/10003662988
Cover Image
A Primer on the Economics of Prescription Pharmaceutical Pricing in Health Insurance Markets
Berndt, Ernst R. - 2011
The pricing of medical products and services in the U.S. is notoriously complex. In health care, supply prices (those received by the manufacturer) are distinct from demand prices (those paid by the patient) due to health insurance. The insurer, in designing the benefit, decides what prices...
Persistent link: https://www.econbiz.de/10013128277
Cover Image
A Primer on the Economics of Prescription Pharmaceutical Pricing in Health Insurance Markets
Berndt, Ernst R. - 2011
The pricing of medical products and services in the U.S. is notoriously complex. In health care, supply prices (those received by the manufacturer) are distinct from demand prices (those paid by the patient) due to health insurance. The insurer, in designing the benefit, decides what prices...
Persistent link: https://www.econbiz.de/10012461776
Cover Image
The Impact of Vertical Integration on Physician Behavior and Healthcare Delivery : Evidence from Gastroenterology Practices
Saghafian, Soroush; Song, Lina; Newhouse, Joseph P.; … - National Bureau of Economic Research - 2023
US healthcare is undergoing a period of substantial change, with many hospitals vertically integrating with physician practices. Such integration could improve quality by promoting care coordination, but could also worsen it by impacting care delivery. Evidence on how physicians alter their...
Persistent link: https://www.econbiz.de/10014226125
Cover Image
Pricing and reimbursement in US pharmaceutical markets
Berndt, Ernst R.; Newhouse, Joseph P. - 2010
Persistent link: https://www.econbiz.de/10008701491
Cover Image
Pricing and reimbursement in US pharmaceutical markets
Berndt, Ernst R.; Newhouse, Joseph P. - 2010
discrimination is highly prevalent among branded pharmaceuticals. We then present a theoretical framework for the pricing of branded … pharmaceuticals, without and then in the presence of prescription drug insurance, noting factors affecting the relative impacts of …
Persistent link: https://www.econbiz.de/10008656716